The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-methyl-3-(2-((triisopropylsilyl)oxy)ethyl)-1-oxa-5-azaspiro[5.5]undeca-7,10-diene-4,9-dione ID: ALA5170181
Chembl Id: CHEMBL5170181
PubChem CID: 164883901
Max Phase: Preclinical
Molecular Formula: C21H35NO4Si
Molecular Weight: 393.60
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)[Si](OCCC1COC2(C=CC(=O)C=C2)N(C)C1=O)(C(C)C)C(C)C
Standard InChI: InChI=1S/C21H35NO4Si/c1-15(2)27(16(3)4,17(5)6)26-13-10-18-14-25-21(22(7)20(18)24)11-8-19(23)9-12-21/h8-9,11-12,15-18H,10,13-14H2,1-7H3
Standard InChI Key: CTHTZTIMQNXHQB-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 393.60Molecular Weight (Monoisotopic): 393.2335AlogP: ┄#Rotatable Bonds: ┄Polar Surface Area: ┄Molecular Species: ┄HBA: ┄HBD: ┄#RO5 Violations: ┄HBA (Lipinski): ┄HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: ┄CX LogD: ┄Aromatic Rings: ┄Heavy Atoms: ┄QED Weighted: ┄Np Likeness Score: ┄
References 1. Dhorma LP, Teli MK, Nangunuri BG, Venkanna A, Ragam R, Maturi A, Mirzaei A, Vo DK, Maeng HJ, Kim MH.. (2022) Positioning of an unprecedented 1,5-oxaza spiroquinone scaffold into SMYD2 inhibitors in epigenetic space., 227 [PMID:34656041 ] [10.1016/j.ejmech.2021.113880 ]